{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:16:23Z","timestamp":1792019783718,"version":"4.4.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/hjh.0b013e32833c211b","type":"journal-article","created":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T05:47:18Z","timestamp":1277358438000},"page":"1829-1835","source":"Crossref","is-referenced-by-count":69,"title":["The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study"],"prefix":"10.1097","volume":"28","author":[{"given":"Katharina","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Lorbeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Haring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten O","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Wallaschofski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian E","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-5491.2007.02025.x","article-title":"Nonalcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens","volume":"24","author":"Targher","year":"2007","journal-title":"Diabet Med"},{"key":"R2-9-20210208","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","article-title":"Nonalcoholic fatty liver disease and increased risk of cardiovascular disease","volume":"191","author":"Targher","year":"2007","journal-title":"Atherosclerosis"},{"key":"R3-9-20210208","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0168-8278(01)00151-9","article-title":"The spectrum of liver disease in the general population: lesson from the Dionysos study","volume":"35","author":"Bellentani","year":"2001","journal-title":"J Hepatol"},{"key":"R4-9-20210208","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0261-5614(99)80015-6","article-title":"Nonalcoholic fatty liver: another feature of the metabolic syndrome?","volume":"18","author":"Cortez-Pinto","year":"1999","journal-title":"Clin Nutr"},{"key":"R5-9-20210208","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ajg.2009.67","article-title":"NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study","volume":"104","author":"Adams","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R6-9-20210208","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gut.2003.027086","article-title":"Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance","volume":"53","author":"Donati","year":"2004","journal-title":"Gut"},{"key":"R7-9-20210208","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","article-title":"Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension","volume":"19","author":"Fallo","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R8-9-20210208","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.3748\/wjg.v13.i47.6419","article-title":"Prevalence of fatty liver disease and its risk factors in the population of South China","volume":"13","author":"Zhou","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R9-9-20210208","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1440-1746.2006.04781.x","article-title":"Effects of nonalcoholic fatty liver disease on the development of metabolic disorders","volume":"22","author":"Fan","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"R10-9-20210208","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/00365520410006431","article-title":"High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease","volume":"39","author":"Friies-Liby","year":"2004","journal-title":"Scand J Gatroenterol"},{"key":"R11-9-20210208","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2174\/138161207781039652","article-title":"Nonalcoholic fatty liver disease in the metabolic syndrome","volume":"13","author":"Palasciano","year":"2007","journal-title":"Curr Pharm Des"},{"key":"R12-9-20210208","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-230X-8-44","article-title":"Risk factors associated with nonalcoholic fatty liver disease in subjects from primary care units. A case\u2013control study","volume":"8","author":"Caballeria","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"R13-9-20210208","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1464-5491.2005.01748.x","article-title":"Recent concepts in nonalcoholic fatty liver disease","volume":"22","author":"Adams","year":"2005","journal-title":"Diabet Med"},{"key":"R14-9-20210208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-230X-7-41","article-title":"Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units","volume":"7","author":"Caballeria","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"R15-9-20210208","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.hjh.0000200508.10324.8e","article-title":"Regional disparities of hypertension prevalence and management within Germany","volume":"24","author":"Meisinger","year":"2006","journal-title":"J Hypertens"},{"key":"R16-9-20210208","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jclinepi.2008.06.010","article-title":"Extended recruitment efforts minimize attrition but not necessarily bias","volume":"62","author":"Haring","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R17-9-20210208","first-page":"234","article-title":"Methods for quality assurance of medical examination in epidemiological field studies: the \u2018Study of Health in Pomerania\u2019 (SHIP)","volume":"62","author":"Ludemann","year":"2000","journal-title":"Gesundheitswesen"},{"key":"R18-9-20210208","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3748\/wjg.v11.i12.1848","article-title":"Hepatic steatosis is associated with an increased risk of carotid atherosclerosis","volume":"11","author":"Volzke","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R19-9-20210208","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gut.2006.115345","article-title":"Menopausal status and hepatic steatosis in a general female population","volume":"56","author":"Volzke","year":"2007","journal-title":"Gut"},{"key":"R20-9-20210208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2007.10.024","article-title":"Impact of fatty liver disease on healthcare utilization and costs in a general population: a 5-year observation","volume":"134","author":"Baumeister","year":"2008","journal-title":"Gastroenterology"},{"key":"R21-9-20210208","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2217\/17455057.5.2.191","article-title":"Nonalcoholic fatty liver disease in women","volume":"5","author":"Suzuki","year":"2009","journal-title":"Womens Health (Lond, Engl)"},{"key":"R22-9-20210208","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-09-0374","article-title":"Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample","volume":"161","author":"Volzke","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R23-9-20210208","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2605.2009.00953.x","article-title":"Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men.","volume":"33","author":"Volzke","year":"2010","journal-title":"Int J Androl"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-201009000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:29:53Z","timestamp":1786040993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201009000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32833c211b","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}